The Europe IVD market is expected to reach over USD 15.5 billion by 2024 according to a new report by Grand View Research, Inc. This expected increase in the demand is ascribed to the presence of novel and promising technologies in clinical laboratories, such as the introduction of Troponin T test by Roche Diagnostics in May, 2011.
Persistent research and development efforts made to introduce automation in laboratories that perform analytical testsare projected to propel the market growth over the forecast period. Clinical laboratory operations require automated analyzers to cope with the large test volumes,which enhance the overall operational workflow. It minimizes the need for dedicated operator training andnegates the risk of human errors. In addition, the rising demand for portable and handheld IVD devicesis one of the major factors pushing forward the growth of the market.
The increasing prevalence of chronic diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising geriatric population coupled with the rising awareness towards early diagnosis in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe IVD market.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market
Further key findings from the study suggest:
·
In 2015, the reagents segment dominated the
Europe IVD market due to its increasing number of applications in the companion
diagnostics area and the introduction of disease specific kits, such as the
XpertTB kit
·
The IVD instruments market is anticipated to show
lucrative growth due to the introduction of portable instruments, such as
MinION Analyzer by Oxford Nanopore, and the availability of various platforms
to performtarget sequence analysis, thereby driving the overall demand
·
Germany is one of the largest segments in 2015
with a share of over 19% owing to the presence of a larger geriatric population
base in this region and the amendment ofthe German lawfor the prevention of
hospital-acquired infections
·
UK is expected to be the fastest growing
regionduring the forecast period.The rising demand for the point-of-care
devices coupled with the government interventions to incorporate innovative,
cost-effective solutions in the healthcare services are expected to drive the
market growth during the forecast period.
·
The hospital-based IVD testing segment held the
largest share of over 45% in 2015. The highprocedure volumes in this segment,
is one of the major reasons resulting inthehigh share and;hence, is anticipated
to maintain its market position over the forecast period.
·
The market players of the Europe IVD market
include Alere, Inc., bioMerieux, Inc., Hologic, Inc. (Gen-Probe), Roche
Diagnostics, Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation,
Abbott Laboratories, Inc., Becton, Dickinson (BD) and Company, Inc., and
Siemens Healthcare GmbH
·
The presence of major IVD market players in
Europe accelerates the penetration of the IVD products throughout the European
Union. For instance, in September 2014, Roche Diagnostics launched the CE
approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring
withenhanced flexibility and automation.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Europe In-Vitro Diagnostics (IVD) Market, by Product (USD Million), 2013 - 2024
·
IVD Instruments
·
IVD Reagents
·
Services
·
Data Management
Europe In-Vitro Diagnostics (IVD) Market, by Technique (USD
Million), 2013 - 2024
·
Immunochemistry
·
Microbiology
·
Molecular diagnostics
·
Hematology
·
Clinical Chemistry
·
Coagulation
·
Other Clinical Instruments
Europe In-Vitro Diagnostics (IVD) Market, by Application (USD
Million), 2013 - 2024
·
Infectious Diseases
·
Diabetes
·
Oncology/Cancer
·
Cardiology
·
Nephrology
·
Autoimmune Diseases
·
Drug Testing
·
Others
Europe In-Vitro Diagnostics (IVD) Market, by End-use (USD Million),
2013 - 2024
·
Hospitals
·
Laboratory
·
Patient self-testing
·
Point-of-care testing
·
Academics
·
Others
Europe In-Vitro Diagnostics (IVD) Market, by Country (USD Million),
2013 - 2024
·
Germany
·
UK
·
France
·
Switzerland
·
Spain
·
Italy
·
Belgium
·
Austria
·
Netherlands
·
Sweden
For press release of this report - http://www.grandviewresearch.com/press-release/europe-in-vitro-diagnostics-ivd-market-analysis
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment